Amgen Deutschland

About Amgen Deutschland

Amgen was founded in 1980 and is now a global leader in independent biotechnology, represented by approximately 31,500 employees in almost 100 countries. As a pioneer in biotechnology, Amgen has four decades of experience in the research, development, and production of innovative human therapeutics. We focus on diseases for which there are few or no treatment options. Millions of patients with serious illnesses worldwide benefit from our therapies every year. Our medicines are used in nephrology, cardiology, hematology, oncology, bone health, chronic inflammatory diseases, and rare diseases. In addition to original preparations, our portfolio also includes biosimilars. In Germany, we work at two locations with approximately 680 employees (as of June 2026) every day to help patients: The Amgen GmbH in Munich was founded in 1989 as a sales company. The focus of approximately 500 employees is on clinical research, approval, and distribution of medicines. Amgen Research (Munich) GmbH is Amgen's largest research site outside the US, specializing in innovative cancer therapies. Around 180 employees (as of June 2026) work on the research and development of BiTE® ("Bispecific T-cell Engager") molecules. More about Amgen in Germany at amgen.de. Information for applicants: Visit our applicant portal with our current job openings at Amgen GmbH and Amgen Research (Munich) GmbH. Our Social Media Guidelines: Please also note our legal notice and our privacy policy: